Eluforsen Shown to Improve Protein Function in CF Patients
A CF treatment candidate called eluforsen improved CFTR protein function in patients with homozygous F508del mutations, a Phase 1 trial shows. Click here to learn more.
Are you a candidate for this therapy? Would you like to try it?
Sorry, there were no replies found.
Log in to reply.